Sara M. Tolaney, MD, MPH, is a medical oncologist specializing in breast oncology. She is Chief of the Division of Breast Oncology and Associate Director of the Susan F. Smith Center for Women’s Cancers at Dana-Farber Cancer Institute, and serves as an Associate Professor of Medicine at Harvard Medical School. Clinically, she focuses on systemic therapy optimization, precision oncology, and clinical trials–integrated care. Her research centers on antibody-drug conjugates, CDK4/6 inhibitors, and immuno-oncology and biomarker-driven trials. She serves on the National Cancer Institute Breast Cancer Steering Committee and is Vice Chair for Late-Stage Development in Breast Cancer in the Alliance for Clinical Trials in Oncology, and she chairs multiple phase 3 trials. Her contributions have been recognized with the Susan G. Komen Rising Star Researcher Award. Dr. Tolaney earned her medical degree from the University of California, San Francisco; completed internal medicine residency at Johns Hopkins; and pursued fellowships in hematology and medical oncology at the Dana-Farber Cancer Institute.
Associate Professor
Medical School
1998 – 2002
Residency
Fellowship